SHOX2 and neoplasm: Quantitative DNA methylation levels for septin 9 (SEPT9) and short-stature homeobox 2 (SHOX2) in the ctDNA proved to be powerful prognostic and molecular staging biomarkers for identifying patients at a higher risk of tumour recurrence [26].